GAMCO Investors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
GAMCO Investors's NVO Position: Q4 2025 in Review
GAMCO Investors sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 4,144 shares — an estimated $230K sold.
GAMCO Investors first reported a position in NVO in Q2 2013 and held it in 17 quarters. The position peaked at $361K in Q4 2015. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.
- GAMCO Investors reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
- GAMCO Investors sold 4,144 Novo Nordisk shares in Q4 2025, an estimated $230K.
- GAMCO Investors first reported a position in Novo Nordisk in Q2 2013 and held it in 17 quarters.
- GAMCO Investors's Novo Nordisk position peaked at $361K in Q4 2015.
- 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.
Based on GAMCO Investors's 13F filing for Q4 2025, filed 5 Feb 2026.